Trial: 202008172

: NCI Protocol 10330, A Phase 2 Study of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

Phase

II

Principal Investigator

Weiss, Mia

Disease Site

Bones and Joints

Learn more about this study at: clinicaltrials.gov